Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 128

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 128
---
 Dec. 14, 2036 |
| Dec. 14, 2016 |     | IL 259891     |     | Organic solvent free compositions comprising protein-polymer 
 conjugates and uses thereof                                  |     | Israel                  |     | Ready for use acetone-free 
 product                    |     | Utility patent  |     | Dec. 14, 2036 |

<div align='center'>78</div>

Patent applications (pending):

| Filing Date   
 Dec. 14, 2016 
 Dec. 14, 2016 
 Dec. 14, 2016 |     | Application Publication No. 
 US 2022/0105240             
 EP 3389736                  
 JP 2023-180906              |     | Title                                                                                    
 Organic solvent free compositions comprising protein-polymer conjugates and uses thereof 
 Organic solvent free compositions comprising protein-polymer conjugates and uses thereof 
 Organic solvent free compositions comprising protein-polymer conjugates and uses thereof |     | Country 
 USA     
 Europe  
 Japan   |     | Product                            
 Ready for use acetone-free product 
 Ready for use acetone-free product 
 Ready for use acetone-free product |     | Type of application 
 Utility Patent      
 Utility Patent      
 Utility Patent      |     | Projected expiry date 
 Dec. 14, 2036         
 Dec. 14, 2036         
 Dec. 14, 2036         |
|:--------------|:----|:----------------------------|:----|:-----------------------------------------------------------------------------------------|:----|:--------|:----|:-----------------------------------|:----|:--------------------|:----|:----------------------|
| Dec. 14, 2016 |     | CA 3006695                  |     | Organic solvent free compositions comprising protein-polymer conjugates and uses thereof |     | Canada  |     | Ready for use acetone-free product |     | Utility Patent      |     | Dec. 14, 2036         |

| 1 | Nominal expiration date                                                                                           
 based on earliest effective filing date. Not including any possible future patent term extensions or adjustments. |

Data Agreement with TiGenix

We entered into a data agreement with TiGenix dated July 20, 2015, or the TiGenix Data Agreement, pursuant to which we licensed microfracture historical data that TiGenix compiled in a study that TiGenix conducted in 2011. The FDA has allowed us to use the licensed data